FDA Approves First Oral Treatment for Postpartum Depression
For Immediate Release: August 04, 2023
Today, the U.S. Food and Drug Administration approved Zurzuvae (zuranolone), the first oral medication indicated to treat postpartum depression (PPD) in adults. PPD is a major depressive episode that typically o... [3699 chars]
Source: FDA.gov
